AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
Wednesday, May 27, 2009 - 06:28
in Health & Medicine
Vienna, 27. May 2009. The atherosclerosis vaccine development program by AFFiRiS AG is receiving financial support from the EU's EUROTRANS-BIO call. The respective project is being carried out in cooperation with German company EMC microcollections GmbH.